Once-weekly semaglutide versus placebo in adults with increased fracture risk: a randomised, double-blinded, two-centre, phase 2 trial. eClinicalMedicine
Shah notes that it can also happen with tirzepatides like Zepbound and Mounjaro, among other medications in the class of drugs known as GLP-1 receptor agonists
To minimize gastrointestinal side effects, clinicians typically employ gradual dose titration, starting at 2.5 mg weekly and increasing by 2.5 mg increments every 4 weeks based on individual tolerance
Women report similar results timelines and side effect profiles as men
NLRP3 inflammasome suppression
Qual Life Res 30(7):20332043 Alhindi Y, Avery A (2022) The efficacy and safety of oral semaglutide for glycaemic management in adults with type 2 diabetes compared to subcutaneous semaglutide, placebo, and other GLP-1 RA comparators: a systematic review and network meta-analysis